(Q35683868)

9 August 2017

1 reference

title

Drosophila melanogaster innate immunity: an emerging role for peptidoglycan recognition proteins in bacteria detection (English)

1 reference

9 August 2017

main subject

Drosophila melanogaster

0 references

bacteria

0 references

author name string

J Royet

series ordinal

1

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 March 2004

1 reference

Cellular and Molecular Life Sciences

9 August 2017

published in

1 reference

9 August 2017

volume

61

1 reference

9 August 2017

issue

5

1 reference

9 August 2017

page(s)

537-546

1 reference

https://scigraph.springernature.com/pub.10.1007/s00018-003-3243-0

9 August 2017

exact match

0 references

cites work

Effects of the nitric oxide donor nitroprusside on no-reflow phenomenon during coronary interventions for acute myocardial infarction

1 reference

12 December 2020

Coronary no-reflow phenomenon: from the experimental laboratory to the cardiac catheterization laboratory

1 reference

12 December 2020

Intracoronary boluses of adenosine and sodium nitroprusside in combination reverses slow/no-reflow during angioplasty: a clinical scenario of ischemic preconditioning

1 reference

12 December 2020

Pharmaceutical interventions for the management of no-reflow

1 reference

12 December 2020

Intense microvascular constriction after angioplasty of acute thrombotic coronary arterial lesions

1 reference

12 December 2020

Treatment of no-reflow and impaired flow with the nitric oxide donor nitroprusside following percutaneous coronary interventions: initial human clinical experience

1 reference

12 December 2020

Frequency, correlates, and clinical implications of myocardial perfusion after primary angioplasty and stenting, with and without glycoprotein IIb/IIIa inhibition, in acute myocardial infarction.

1 reference

12 December 2020

Management of 'no-reflow' complicating reperfusion therapy

1 reference

12 December 2020

Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial

1 reference

12 December 2020

Pharmacological approach of no-reflow phenomenon related with percutaneous coronary interventions.

1 reference

12 December 2020

Frequency of slow coronary flow following successful stent implantation and effect of Nitroprusside.

1 reference

12 December 2020

Treatment of slow/no-reflow phenomenon with intracoronary nitroprusside injection in primary coronary intervention for acute myocardial infarction.

1 reference

12 December 2020

10.1007/S00018-003-3243-0

Identifiers

DOI

1 reference

9 August 2017

1 reference